Form D — Galvanize Therapeutics, Inc.
0001659073-25-000001 · filed 2025-09-11
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $141,066,486
- Total sold
- $96,130,465
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Galvanize Therapeutics, Inc.
- CIK
- 1659073
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 3200 Bridge Parkway
Redwood City, CA 94065 - Phone
- 650-268-4252
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Doug Godshall · Executive OfficerRedwood City, CA Find on LinkedIn ↗
-
Seth Harrison · DirectorRedwood City, CA Find on LinkedIn ↗
-
Jonathan Waldstreicher · Executive OfficerRedwood City, CA Find on LinkedIn ↗
-
Antoine Papiernik · DirectorRedwood City, CA Find on LinkedIn ↗
-
Zack Scott · DirectorRedwood City, CA Find on LinkedIn ↗
-
David Lewis · DirectorRedwood City, CA Find on LinkedIn ↗
-
Steve Anheier · Executive OfficerRedwood City, CA Find on LinkedIn ↗
View original on SEC EDGAR.